Lupia, T.; Corcione, S.; Fornari, V.; Rizzello, B.; Bosio, R.; Brusa, M.T.; De Rosa, F.G.
Visceral Leishmaniasis after Anti-Interleukin 17A (IL-17A) Therapy in a Patient Affected by Psoriatic Arthritis. Trop. Med. Infect. Dis. 2022, 7, 319.
https://doi.org/10.3390/tropicalmed7100319
AMA Style
Lupia T, Corcione S, Fornari V, Rizzello B, Bosio R, Brusa MT, De Rosa FG.
Visceral Leishmaniasis after Anti-Interleukin 17A (IL-17A) Therapy in a Patient Affected by Psoriatic Arthritis. Tropical Medicine and Infectious Disease. 2022; 7(10):319.
https://doi.org/10.3390/tropicalmed7100319
Chicago/Turabian Style
Lupia, Tommaso, Silvia Corcione, Valentina Fornari, Barbara Rizzello, Roberta Bosio, Maria Teresa Brusa, and Francesco Giuseppe De Rosa.
2022. "Visceral Leishmaniasis after Anti-Interleukin 17A (IL-17A) Therapy in a Patient Affected by Psoriatic Arthritis" Tropical Medicine and Infectious Disease 7, no. 10: 319.
https://doi.org/10.3390/tropicalmed7100319
APA Style
Lupia, T., Corcione, S., Fornari, V., Rizzello, B., Bosio, R., Brusa, M. T., & De Rosa, F. G.
(2022). Visceral Leishmaniasis after Anti-Interleukin 17A (IL-17A) Therapy in a Patient Affected by Psoriatic Arthritis. Tropical Medicine and Infectious Disease, 7(10), 319.
https://doi.org/10.3390/tropicalmed7100319